Can low total IgG increase recurrent or persistent infections even when pathogen-specific antibodies are detectable?

Low total IgG is a clinically meaningful marker of impaired antibody-mediated defense, especially when it is persistent and accompanied by recurrent, severe, or persistent infections. This remains true even if selected pathogen-specific antibody tests are positive.

Clinical evidence

• Low IgG is associated with more bacterial respiratory infections and pneumonia in antibody-deficient adults; higher trough IgG during immunoglobulin replacement is generally associated with fewer infections.
• Risk is most compelling with profound deficiency: IgG <400 mg/dL is commonly considered severe and, together with recurrent/severe/persistent infection, supports consideration of immunoglobulin replacement.
• In secondary immunodeficiency associated with hematologic malignancy, ≥3 infections in the preceding year predicted later severe infection requiring hospitalization or intravenous antibiotics.
• Mild-to-moderate reductions (approximately 400–600/700 mg/dL) do not confer uniform risk. Infection history, persistence of the abnormality, lung disease, immunosuppression, IgA/IgM levels, and functional antibody responses materially change interpretation.

Mechanistic and functional implications

• Total IgG concentration does not directly measure protective antibody function. IgG-mediated defense depends on neutralization, opsonization, complement-related effector activity, and durable antigen-specific responses.
• Detectable binding antibodies may still lack adequate avidity, neutralizing capacity, serotype breadth, or opsonophagocytic/bactericidal activity. For encapsulated bacteria, these functional activities—not binding antibody alone—are the closer correlate of protection.
• Assessment may include pneumococcal serotype-specific IgG before and about four weeks after PPSV23 plus protein-antigen responses (tetanus/diphtheria). A commonly used adult benchmark is response to ≥70% of tested PPSV23 serotypes, although thresholds vary; 1.3 μg/mL (PPSV23) and 0.35 μg/mL (conjugate vaccine) are not interchangeable.

Bottom line

• The claim is supported: low total IgG can increase susceptibility to recurrent or persistent infection despite detectable pathogen-specific antibodies. Repeated immunoglobulin testing, secondary-cause assessment, infection phenotype, and functional vaccine-response testing determine its practical significance.